Redwood City, CA, United States of America

James Andrus

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Leland Stanford Junior University. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Andrus. Retrieved from https://idiyas.com/inventor/james-andrus-a1kt1cjn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Treatments: The Contributions of James Andrus

Introduction: James Andrus, an inventor based in Redwood City, California, has made significant strides in the field of pharmaceuticals. With a total of two patents to his name, his work focuses on addressing toxic effects associated with therapeutic agents.

Latest Patents: One of James Andrus’ latest patents revolves around the use of N-acetylcysteine compositions and methods for treating and preventing drug toxicity. His invention provides pharmaceutical compositions aimed at mitigating the toxic effects of various therapeutic agents. By utilizing a toxicity-reducing amount of N-acetylcysteine, either alone or in combination with a therapeutically effective amount of a therapeutic agent, the treatment can significantly enhance patient outcomes. His research emphasizes the importance of administering N-acetylcysteine to counteract the heightened oxidative stress and decreased levels of cysteine/glutathione that can exacerbate side effects from treatments.

Career Highlights: Throughout his career, James Andrus has dedicated his efforts to innovating pharmaceutical solutions that improve patient care and outcomes. His focus on drug toxicity has positioned him as a valuable figure within the medical and pharmaceutical communities. Working at the Leland Stanford Junior University, he has contributed to advancing therapeutic strategies that prioritize patient safety.

Collaborations: James Andrus has collaborated with esteemed colleagues, including Leonard A. Herzenberg and Leonore A. Herzenberg. These collaborations have further enriched his research, allowing for a multidisciplinary approach to addressing complex issues related to drug toxicity.

Conclusion: James Andrus exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborative work underscore the importance of developing effective treatments that mitigate the side effects of therapeutic agents. As he continues to contribute through research and invention, the impact of his work is likely to resonate within both the medical community and patient populations for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…